QualityStocks News - 22nd Century Group Delivers 2.7Mln SPECTRUM Research Cigarettes under 5-Year Government Contract

Share Article

Researchers will conduct dozens of studies on the SPECTRUM line to evaluate nicotine affects and cessation.

...the only company in the world capable of producing cigarettes with such a wide range of nicotine levels...

QualityStocks would like to highlight 22nd Century Group, Inc., a plant biotechnology company whose proprietary technology allows for the level of nicotine and other nicotinic alkaloids (e.g., nornicotine, anatabine and anabasine) in the tobacco plant to be decreased or increased through genetic engineering and breeding. 22nd Century owns or is the exclusive licensee of 102 issued patents in 78 countries plus an additional 37 pending patent applications.

In the company’s news yesterday,

22nd Century Group announced it has delivered an additional 2.7 million SPECTRUM® research cigarettes.

The SPECTRUM line is comprised of a series of cigarette styles with a fixed amount of tar, but with varying nicotine yields. The product line features 24 styles, 11 regular and 13 menthol versions, with eight levels of nicotine content. The most prevalent style of SPECTRUM has approximately 97 percent less nicotine than "light" cigarettes on the market.

22nd Century developed SPECTRUM for NIDA, a department of the National Institutes of Health (NIH). Since the product is for independent research purposes only, SPECTRUM will not be sold as a commercial cigarette.

"As the only company in the world capable of producing cigarettes with such a wide range of nicotine levels, 22nd Century was chosen to supply its proprietary SPECTRUM research cigarettes as a subcontractor under a five-year federal government contract," Joseph Pandolfino, 22nd Century's CEO stated in the press release.

22nd Century said dozens of research studies will be conducted with SPECTRUM to observe smoking cessation; compare how different nicotine levels in cigarettes affect smoking behavior and exposure to smoke; and to determine whether there is a threshold nicotine level in cigarettes which does not produce dependence.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for The QualityStocks Daily Newsletter, please visit http://www.QualityStocks.net

To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage

To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks

Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Editor
Visit website